Diabetes & Endocrinologyamylin analogueobesity
Petrelintide: A Promising Human Amylin Analogue for Long-Term Obesity Management
By MedXY|Oct 3, 2026
Petrelintide, a novel once-weekly human amylin analogue, demonstrates significant bodyweight reduction versus placebo in adults with obesity, with favorable gastrointestinal tolerability, supporting its potential as a long-term obesity ther